Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5064896 | 0.82 | GRM2 (0.31) | — | |
| SCHEMBL218875 | 0.82 | GRM2 (0.31) | — | |
| SCHEMBL7825536 | 0.80 | — | — | |
| SCHEMBL15667879 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL471787 | 0.80 | — | — | |
| SCHEMBL675849 | 0.80 | — | — | |
| SCHEMBL5352667 | 0.80 | — | — | |
| SCHEMBL471784 | 0.80 | — | — | |
| SCHEMBL5961836 | 0.79 | — | — | |
| SCHEMBL31178055 | 0.79 | NPSR1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0004968-B1 | NORBORNENE(-ANE) DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PERFUMING AGENTS | FIRMENICH SA (CH) | 1981-10-21 | — | — | EP | claimed |
| EP-0004968-A2 | Norbornene(-ane) derivatives, process for their preparation and their use as perfuming agents | FIRMENICH SA (CH) | 1979-10-31 | — | — | EP | claimed |
| US-20250115693-A1 | POLYMER COMPOUND, REACTIVE COMPOUND, POLYMER CROSSLINKING AGENT, POLYMER MODIFIER, CROSSLINKED PART FORMING METHOD, POLYMER MODIFYING METHOD, POLYMER COMPOUND POLYMERIZING METHOD, AND POLYMER COMPOUND DECOMPOSING METHOD | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2025-04-10 | — | — | US | disclosed |
| EP-4527868-A2 | COMPOUND AND POLYMERIC COMPOUND INCLUDING SAID COMPOUND | Japan Science and Technology Agency (JP) | 2025-03-26 | — | — | EP | disclosed |
| EP-4471070-A1 | POLYMER COMPOUND, REACTIVE COMPOUND, POLYMER CROSSLINKING AGENT, POLYMER MODIFIER, METHOD FOR FORMING A CROSSLINKED SECTION, METHOD FOR POLYMER MODIFICATION, AND METHOD FOR POLYMERIZING AND METHOD FOR DECOMPOSING POLYMER COMPOUND | Japan Science and Technology Agency (JP) | 2024-12-04 | — | — | EP | disclosed |
| US-12145938-B2 | Compound and polymer compound containing the compound | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2024-11-19 | — | — | US | disclosed |
| CN-118871481-A | Polymer compound, reactive compound, polymer crosslinking agent, polymer modifier, method for forming crosslinked portion, method for modifying polymer, method for polymerizing polymer compound, and method for decomposing polymer compound | 国立研究开发法人科学技术振兴机构 | 2024-10-29 | — | — | CN | disclosed |
| WO-2024205770-A1 | CARBOHYDRATE-POLYMER CONJUGATES FOR TUNABLE PROTEIN BINDING AND METHODS OF USE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-10-03 | — | — | WO | disclosed |
| US-20240217976-A2 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2024-07-04 | — | — | US | disclosed |
| CN-111788206-B | Compound and polymer compound containing the same | 国立研究开发法人科学技术振兴机构 | 2024-03-08 | — | — | CN | disclosed |
| WO-2023145203-A1 | POLYMER COMPOUND, REACTIVE COMPOUND, POLYMER CROSSLINKING AGENT, POLYMER MODIFIER, METHOD FOR FORMING A CROSSLINKED SECTION, METHOD FOR POLYMER MODIFICATION, AND METHOD FOR POLYMERIZING AND METHOD FOR DECOMPOSING POLYMER COMPOUND | 国立研究開発法人科学技術振興機構 | 2023-08-03 | — | — | WO | disclosed |
| EP-0402881-A1 | Process for improving the coefficient of traction. | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1990-12-19 | — | — | EP | disclosed |
| US-4549982-A | ORGANOLEPTIC | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1985-10-29 | — | — | US | disclosed |
| EP-0026369-B1 | CARBAMATES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1984-08-08 | — | — | EP | disclosed |
| US-4351748-A | COSMETICS; DETERGENTS; DEODORIZING; MELON ODOR | FIRMENICH SA (CH) | 1982-09-28 | — | — | US | disclosed |
| EP-0004968-B1 | NORBORNENE(-ANE) DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PERFUMING AGENTS | FIRMENICH SA (CH) | 1981-10-21 | — | — | EP | disclosed |
| EP-0026369-A2 | Carbamates, their preparation and pharmaceutical compositions containing them | BASF Aktiengesellschaft (DE) | 1981-04-08 | — | — | EP | disclosed |
| US-4252728-A | PERFUMES | FIRMENICH SA (CH) | 1981-02-24 | — | — | US | disclosed |
| EP-0004968-A2 | Norbornene(-ane) derivatives, process for their preparation and their use as perfuming agents | FIRMENICH SA (CH) | 1979-10-31 | — | — | EP | disclosed |
| EP-0004968-A2 | Norbornene(-ane) derivatives, process for their preparation and their use as perfuming agents | FIRMENICH SA (CH) | 1979-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240217976-A2 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | RAD51, MDM2, UBE2D3 | SLC1A2 4806/4885SLC1A1 4653/4885 |
| US-12145938-B2 | Compound and polymer compound containing the compound | RAD51, MDM2, UBE2D3 | SLC1A2 4806/4885SLC1A1 4653/4885 |
| US-20250115693-A1 | POLYMER COMPOUND, REACTIVE COMPOUND, POLYMER CROSSLINKING AGENT, POLYMER MODIFIER, CROSSLINKED PART FORMING METHOD, POLYMER MODIFYING METHOD, POLYMER COMPOUND POLYMERIZING METHOD, AND POLYMER COMPOUND DECOMPOSING METHOD | SMCHD1, PARG, SSRP1 | SLC1A2 4523/4885SLC1A1 4679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.